Clinical Trial

A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis

Name: A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis — clinical trial record (NCT06926582)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Record status

This record was last updated April 13, 2025 (before its estimated July 9, 2026 completion). Its status may not reflect the trial's current state.

Summary

This study has been designed to explore the clinical efficacy and safety of HS-10374 in the treatment of mild-to-moderate plaque psoriasis.

Trial Details

NCT Number	NCT06926582
Lead Sponsor	Hansoh BioMedical R&D Company
Conditions	Psoriasis
Enrollment	305 participants
Start Date	2025-04-09
Primary Completion	2026-07-09 (estimated)
Study Completion	2026-12-09 (estimated)
Updated on ClinicalTrials.gov	2025-04-13